Synlett, Table of Contents Synlett 2023; 34(02): 168-172DOI: 10.1055/a-1951-1985 letter A Novel Synthesis of 5E-Isomer-Free Carboprost Methyl Ester Fangdao Wang , Meng Wang∗Recommend Article Abstract Buy Article All articles of this category Abstract A macrocyclic lactone strategy for the synthesis of 5E-isomer-free carboprost methyl ester was developed for the first time. The macrocyclic lactone being free of 5E-isomer can be easily prepared from modified Corey lactone. The key intermediate could be used as a building scaffold to prepare carboprost methyl ester and other prostaglandins effectively. Key words Key wordsmacrocyclic lactone - carboprost - Corey lactone - prostaglandins - Wittig reaction - Grignard reaction Full Text References References and Notes 1 Collins PW, Djuric SW. Chem. Rev. 1993; 93: 1533 2 Das S, Chandrasekhar S, Yadav JS, Gre R. Chem. Rev. 2007; 107: 3286 3a Peng H, Chen FE. Org. Biomol. Chem. 2017; 15: 6281 3b Yan M, Rerko RM, Platzer P, Dawson D, Willis J, Tong M, Lawrence E, Lutterbaugh J, Lu S, Willson JK. V, Luo G, Hensold J, Tai H.-H, Wilson K, Markowitz SD. Proc. Natl. Acad. Sci. U.S.A. 2004; 101: 17468 4 Zhang F, Zeng J, Gao M, Wang L, Chen GQ, Lu Y, Zhang X. Nat. Chem. 2021; 13: 692 5a Schaaf TK, Corey EJ. J. Org. Chem. 1972; 37: 2921 5b Corey EJ, Terashima S, Ramwell PW, Jessup R, Weinshenker NM, Floyd DM, Crosby GA. J. Org. Chem. 1972; 37: 3043 5c Corey EJ, Moinet G. J. Am. Chem. Soc. 1973; 95: 6831 5d Corey EJ, Mann J. J. Am. Chem. Soc. 1973; 95: 6832 5e Corey EJ, Moinet G. J. Am. Chem. Soc. 1973; 95: 7185 5f Bindra JS, Grodski A, Schaaf TK, Corey EJ. J. Am. Chem. Soc. 1973; 95: 7522 5g Corey EJ, Ensley HE. J. Am. Chem. Soc. 1975; 97: 6908 5h Corey EJ, Imwinkelried R, Pikul S, Xiang Y. J. Am. Chem. Soc. 1989; 111: 5493 5i Corey EJ, Cheng X.-M. The Logic of Chemical Synthesis. John Wiley & Sons; New York: 1989: 250 5j Ogawa Y, Nunomoto M, Shibasaki M. J. Org. Chem. 1986; 51: 1625 6a Yankee EW, Axen U, Bundy GL. J. Am. Chem. Soc. 1974; 96: 5865 6b Cooper EL, Yankee EW. J. Am. Chem. Soc. 1974; 96: 5876 7a Péter BL, Zsuzsanna K, Irén HB, István L, Imre J, László F, Csaba V, Ágnes NB. WO2017093770, 2016 7b Shripad BK, Govindrao PA, Madhukar PN. WO2008081191, 2008 8 Shankar M, Mohan HR, Prasad UV, Krishna MH, Rao PM, Lakshmikumar T, Subbaraju GV. Asian J. Chem. 2013; 25: 913 9 González-González CA, Fuentes-Benítez A, Cuevas-Yáñez E, Corona-Becerril D, González-Romero C, González-Calderón D. Tetrahedron Lett. 2013; 21: 2726 10 Rey MD. L. A, Martínez-Pérez JA, Fernández-Gacio A, Halkes K, Fall Y, Granja J, Mouriño A. J. Org. Chem. 1999; 64: 3196 11 Bundy GL, Peterson DC, Cornette JC, Miller WL, Spilman CH, Wilks JW. J. Med. Chem. 1983; 26: 1089 12 Procedures and Analytical Data of Compound 19A mixture of compound 18 (120.0 g, 262.8 mmol), Ph3P (183.5 g, 700.4 mmol), and 2,2′-dipyridyl disulfide (154.0 g, 700.0 mmol) in 4.0 L of oxygen-free toluene was stirred in an atmosphere of nitrogen for overnight at room temperature, and another 4.0 L of oxygen-free toluene was added. The mixture was heated at reflux for 15 h. (The toluene had been deoxygenated with a vigorous stream of nitrogen introduced through a gas dispersion tube for at least 30 min prior to use). The reaction mixture was cooled to room temperature and concentrated in vacuo. The residue was triturated with small volume of MTBE and filtered, thereby removing substantial amounts of triphenylphosphine oxide. The filtrate was reconcentrated and purified by chromatography on silica gel to give 90.0 g of compound 19 (78% yield) as a colorless oil; Rf = 0.7 (PE/EtOAc = 20:1).1H NMR (400 MHz, CDCl3): δ = 5.50 (m, 1 H), 5.12 (s, 1 H), 4.57 (m, 1 H), 4.11–3.91 (m, 1 H), 3.90–3.56 (m, 3 H), 3.42 (m, 1 H), 2.40–2.37 (m, 4 H), 2.26 (m, 1 H), 2.18–1.47 (m, 13 H), 0.84 (s, 9 H), 0.00 (s, 6 H). 13C NMR (101 MHz, CDCl3): δ = 173.9, 173.7, 131.0, 130.9, 128.0, 127.9,100.0, 96.7, 79.0, 75.6, 74.2, 73.6, 62.7, 62.1, 60.7, 60.5, 52. 4, 41.2, 40.4, 39.6, 36.1, 31.0, 30.9, 27.1, 26.9, 26.7, 25.9, 25.5, 25.4, 25.3, 20.0, 19.4, 18.3. HRMS (ESI): m/z calcd for C24H42O5NaSi [M + Na]+: 461.2694; found: 461.2697. 13 Hayashi K, Tanimoto H, Zhang H, Morimoto T, Nishiyama Y, Kakiuchi K. Org. Lett. 2012; 14: 5728 14 Procedures and Analytical Data of Compound 22 To a stirred solution of compound 21 (47.0 g, 112.3 mmol) in MeOH (235 mL) at room temperature was added PPTS (3.0 g, 11.9 mmol), and the resulting mixture was allowed to stir overnight. Solvents were evaporated under reduced pressure, and the residue was dissolved in EtOAc and washed with saturated sodium hydrogen bicarbonate solution. After drying with anhydrous sodium sulfate, the solution was concentrated to give the crude residue, which was recrystallized with EtOAc and PE to give compound 22 (37.5 g, 90%) as a white solid; Rf = 0.2 (PE/EtOAc = 3:1). 1H NMR (400 MHz, CDCl3): δ = 6.66 (dd, J = 15.6, 8.8 Hz, 1 H), 6.30 (d, J = 15.6 Hz, 1 H), 5.38 (td, J = 11.2, 4.8 Hz, 1 H), 5.22 (m, 2 H), 4.04 (td, J = 13.2, 8.0 Hz, 1 H), 2.65–2.36 (m, 7 H), 2.26 (td, J = 13.2, 5.2 Hz, 1 H), 2.12–1.60 (m, 4 H), 1.40–1.10 (m, 10 H), 0.88 (t, J = 6.8 Hz, 3 H). 13C NMR (101 MHz, CDCl3): δ = 200.4, 173.4, 145.9, 132.1, 131.8, 126.9, 72.2, 45.5, 41.0, 40.8, 36.0, 31.5, 26.8, 25.3, 23.8, 22.5, 14.0. HRMS (ESI): m/z calcd for C20H30O4Na [M + Na]+: 357.2036; found: 357.2038. 15 Procedures and Analytical Data of Compound 14 The key intermediate 14 was purified by column chromatography on silica gel eluting with DCM/acetone/Et3N = 5:1:0.01) from a mixture of epimer 25 (5.0 g) to afford pure compound 14 (2.75 g, 55%) and mixture of epimers (2.5 g); Rf = 0.2 (DCM/MeOH = 15:1). 1H NMR (400 MHz, CDCl3): δ = 5.56 (d, J = 15.6 Hz, 1 H), 5.35 (dd, J = 15.6, 9.2 Hz, 1 H), 5.27 (m, 1 H), 3.77 (dd, J = 16.4, 8.0 Hz, 1 H), 2.55 (dd, J = 14.8, 7.6 Hz, 1 H), 2.35–1.40 (m, 15 H), 1.10 (m, 9 H), 0.81 (t, J = 6.4 Hz, 3 H). 13C NMR (101 MHz, CDCl3): δ = 173.5, 140.9, 127.6, 127.4, 73.0, 45.4, 42.9, 40.4, 32.2, 27.9, 26.8, 26.7, 23.8, 22.6, 14.0. HRMS (ESI): m/z calcd for C21H34O4Na [M + Na]+: 373.2349; found: 373.2350. 16 Procedures and Analytical Data of Carboprost Methyl Ester To a stirred solution of compound 14 (2.5 g, 7.13 mmol) in 15 mL of MeOH was added 3 N NaOH (5 ml, 15 mmol), the reaction was continued for approximately 5 h; the starting material had disappeared (checked by TLC). The solvent was evaporated under reduced pressure to the residue, then acidified with 1 N HCl (15.0 ml) and extracted with EtOAc (3 × 30 mL), the organic layers were combined and evaporated under reduced pressure to give crude compound carboprost, which was dissolved in acetone (20 mL). To the stirred solution of compound carboprost in acetone was added DBU (2.5 g, 16.4 mmol) and MeI (2.5 g, 17.6 mmol). The resulting mixture was allowed to stir overnight, the starting material had disappeared (checked by TLC). Solvents were evaporated under reduced pressure to give the residue, which was dissolved with EtOAc and washed with water (10 mL) and brine (10 mL). Organic layer was evaporated under reduced pressure to the residue, which was purified by silica gel chromatography to afford compound carboprost methyl ester (2.2 g, 81% in two steps) as white solid; Rf = 0.2 (DCM/MeOH = 10:1). 1H NMR (400 MHz, CDCl3): δ = 5.65 (d, J = 15.6 Hz, 1 H), 5.48 (dd, J = 15.6, 9.2 Hz, 1 H), 5.40 (m, 2 H), 4.19 (d, J = 3.6 Hz, 1 H), 3.90 (s, 1 H), 3.67 (s, 3 H), 2.56 (d, J = 4.8 Hz, 1 H), 2.30–2.27 (m, 5 H), 2.20–2.09 (m, 4 H), 1.80–1.60 (m, 5 H), 1.52 (m, 3 H), 1.25 (m, 8 H) , 0.88 (t, J = 6.8 Hz, 3 H). 13C-NMR (101 MHz, CDCl3): δ = 174.4, 139.2, 129.5, 129.3, 128.8, 78.1, 72.8, 72.7, 55.8, 51.6, 50.6, 42.9, 42.8, 33.4, 32.3, 27.4, 26.6, 25.5, 24.8, 23.9, 22.6, 14.1. HRMS (ESI): m/z calcd for C22H38O5Na [M + Na]+: 405.2611; found: 405.2613. [α]D +27.9 (c = 0.81, ethanol); lit.6a: [α]D +24 (c = 0.81, ethanol). Supplementary Material Supplementary Material Supporting Information